Toxicodynamics: How Chemicals Harm Cells

  • Philip C. Burcham


Understanding how small molecules comprising just a few dozen or less atoms inflict permanent harm upon complex living cells – which contain thousands upon thousands of metabolites, genes, proteins and interconnected signalling networks – is a central concern in modern toxicology. While toxicologists were long restricted to observational descriptions of morphological changes in dying cells, modern developments in chemistry and molecular biology opened the door to new mechanistic understandings of toxicity. One useful concept emerging from this effort proposes noxious xenobiotics bind selectively to ‘toxicity receptors’ in much the same way medicinal agents target ‘drug receptors’ to elicit a pharmacological response. An even more influential insight recognises that instead of inducing toxicity via transient interactions with receptor proteins, many toxic xenobiotics instead undergo enzyme-catalysed conversion to electrophilic metabolites that react chemically with cell macromolecules. This chapter explores the basic properties of reactive metabolites that influence their toxicological properties together with the major deleterious consequences of reactive metabolite formation within tissues, including adduct formation, calcium dyshomeostasis, oxidative stress, lipid peroxidation, apoptosis and kinase activation.


Direct-acting toxicants Metabolism-dependent toxicants Receptors Computational toxicology Metabolite stability Electrophiles Covalent binding Calcium dyshomeostasis Oxidative stress Lipid peroxidation Apoptosis Kinase signalling 

Going Further

  1. Attene-Ramos MS, et al. The Tox21 robotic platform for the assessment of environmental chemicals – from vision to reality. Drug Discov Today. 2013. pii: S1359–6446(13)00161-X. doi: 10.1016/j.drudis.2013.05.015. Epub 2013 May 31.
  2. Baillie TA. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chem Res Toxicol. 2008;21:129–37.PubMedCrossRefGoogle Scholar
  3. Boverhof DR et al. Transgenic animal models in toxicology: historical perspectives and future outlook. Toxicol Sci. 2011;121:207–33.PubMedCrossRefGoogle Scholar
  4. Fang J et al. Bioinformatic analysis of xenobiotic reactive metabolite target proteins and their interacting partners. BMC Chem Biol. 2009;9:5. doi: 10.1186/1472-6769-9-5.PubMedCrossRefGoogle Scholar
  5. Fritz KS, Petersen DR. An overview of the chemistry and biology of reactive aldehydes. Free Radic Biol Med. 2013;59:85–91.PubMedCrossRefGoogle Scholar
  6. Guengerich FP, Liebler DC. Enzymatic activation of chemicals to toxic metabolites. Crit Rev Toxicol. 1985;14:259–307.PubMedCrossRefGoogle Scholar
  7. Hanzlik RP et al. Filling and mining the reactive metabolite target protein database. Chem Biol Interact. 2009;179:38–44.PubMedCrossRefGoogle Scholar
  8. Irving RM, Elfarra AA. Role of reactive metabolites in the circulation in extrahepatic toxicity. Expert Opin Drug Metab Toxicol. 2012;8:1157–72.PubMedCrossRefGoogle Scholar
  9. Jacobs AT, Marnett LJ. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc Chem Res. 2010;43:673–83.PubMedCrossRefGoogle Scholar
  10. Leung L et al. Metabolic activation in drug-induced liver injury. Drug Metab Rev. 2012;44:18–33.PubMedCrossRefGoogle Scholar
  11. Liebler DC. Protein damage by reactive electrophiles: targets and consequences. Chem Res Toxicol. 2008;21:117–28.PubMedCrossRefGoogle Scholar
  12. Liebler DC, Guengerich FP. Elucidating mechanisms of drug-induced toxicity. Nat Rev Drug Discov. 2005;4:410–20.PubMedCrossRefGoogle Scholar
  13. Lopachin RM et al. Application of the hard and soft, acids and bases (HSAB) theory to toxicant–target interactions. Chem Res Toxicol. 2012;25:239–51.PubMedCrossRefGoogle Scholar
  14. Maehle A-H et al. The emergence of the drug receptor theory. Nat Rev Drug Discov. 2002;1:637–41.PubMedCrossRefGoogle Scholar
  15. Minowa Y et al. Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats. Toxicology. 2012;297:47–56.PubMedCrossRefGoogle Scholar
  16. Orrenius S et al. Cell death mechanisms and their implications in toxicology. Toxicol Sci. 2011;119:3–19.PubMedCrossRefGoogle Scholar
  17. Park BK et al. Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov. 2011a;10:292–306.PubMedCrossRefGoogle Scholar
  18. Park BK et al. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem Biol Interact. 2011b;192:30–6.PubMedCrossRefGoogle Scholar
  19. Stachulski AV et al. The generation, detection, and effects of reactive drug metabolites. Med Res Rev. 2012. doi: 10.1002/med.21273. Epub 2012 Oct 22.PubMedGoogle Scholar
  20. Stepan AF et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol. 2011;24:1345–410.PubMedCrossRefGoogle Scholar
  21. Vedani A et al. VirtualToxLab – a platform for estimating the toxic potential of drugs, chemicals and natural products. Toxicol Appl Pharmacol. 2012;261:142–53.PubMedCrossRefGoogle Scholar
  22. West JD, Marnett LJ. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol. 2006;19:173–94.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  • Philip C. Burcham
    • 1
  1. 1.School of Medicine and PharmacologyThe University of Western AustraliaPerthAustralia

Personalised recommendations